- Policy
- Lee to pledge ‘incentives for homegrown new drugs'
- by Lee, Jeong-Hwan Feb 16, 2022 05:51am
- Presidential candidate Jae-Myung Lee of the Democratic Party of Korea is positively reviewing reinforcing incentives for new drugs that were developed by Korean pharmaceutical companies or conducted trials in Korea, establishing a megafund for the pharmaceutical industry, and introducing a pre-approval system for prescriptions of ultra-high
- Policy
- There's plenty of COVID-19 PO medicine, Regkirona
- by Lee, Jeong-Hwan Feb 16, 2022 05:51am
- The quarantine authorities said they have secured sufficient supplies of COVID-19 oral treatments in Korea and will continue to consider additional purchases depending on the quarantine situation. The quarantine authorities also said they would consider using the budget for purchasing Regkirona as an oral drug as Regkirona, an antibody treatm
- Policy
- High-dose ‘pyridoxine’ to be classified as an Rx drug
- by Lee, Hye-Kyung Feb 14, 2022 05:54am
- The high-dose Vitamin B6 ‘Pyridoxine Hydrochloride 300mg’ is likely to be classified as a prescription drug. Although pyridoxine doses up to 250mg are classified as a health functional food abroad, experts reached a consensus that the 300mg dose of the same drug should be classified as a prescription drug in consideration of the side e
- Policy
- The selection of benefit revaluation is approaching
- by Lee, Hye-Kyung Feb 14, 2022 05:54am
- The pharmaceutical industry has suggested that it is difficult to review and predict the criteria for selecting evaluation targets as the targets for benefit revaluation were disclosed in the current year during the pilot project of Choline alfoscerate and Bilberry Fruit Dried Ext, Avocado-Soya, Ginkgo Leaf Ext, Silymarin, and Vitis Vinifera. I
- Policy
- Bill to stop reimbursement of drugs upon disposition
- by Lee, Jeong-Hwan Feb 11, 2022 05:55am
- A bill to immediately stop prescriptions of pharmaceuticals that have received sales suspension dispositions due to expedient acts such as rebates at hospitals and clinics is being pushed for legislation. If enacted, the bill will immediately suspend reimbursement of pharmaceuticals that will receive administrative dispositions and stop h
- Policy
- “Will provide systemic support for homegrown mRNA vaccines"
- by Lee, Hye-Kyung Feb 11, 2022 05:55am
- The Ministry of Food and Drug Safety promised to spare no effort in providing institutional support so that domestic companies can foster mRNA vaccine manufacturing and development capabilities. On the 9th, Food and Drug Safety Minister Gang-lip Kim held a roundtable meeting with vaccine R&D developers and experts that are participating
- Policy
- It's hard to handle free national support for self-diagnosis
- by Lee, Jeong-Hwan Feb 11, 2022 05:55am
- Prime Minister Kim Bu-Gyeom expressed disapproval of the ruling party's proposed "free support for self-diagnosis kits for the whole country." This is because the production of diagnostic kits is currently insufficient to cover free distribution across the country. On the 8th, Prime Minister Kim responded to a question from Rep. Shin Hyun-
- Policy
- Following Kymriah, Zolgensma is also about to be reviewed
- by Lee, Tak-Sun Feb 9, 2022 06:09am
- So-called "one-shot treatments" that treat specific rare diseases with one administration are speeding up the reimbursement. Following Kymriah, which treats blood cancer such as leukemia and lymphoma, Zolgensma (Onasemnogene Abeparvovec), which treats a rare disease called SMA, is also set to be reviewed by HIRA's Drug Reimbursement Evaluati
- Policy
- Novavax vaccine passed the national lot release procedure
- by Lee, Hye-Kyung Feb 9, 2022 06:09am
- 840,000 doses of Nuvaxovid PFS, a Novavax vaccine, have been released in the national lot. The MFDS (Minister Kim Kang-rip) announced on the 8th that SK Bioscience has approved 840,000 Nuvaxovid PFS manufactured in Korea for the first time. Nuvaxovid PFS, which was approved for shipment to the country this time, is a vaccine manufactured
- Policy
- Focus on the possibility of NovaVax vaccine booster shot
- by Lee, Tak-Sun Feb 8, 2022 05:55am
- Experts expressed great interest in the cross-vaccination use of the vaccine during the Novavax COVID-19 vaccine screening process approved in Korea on the 12th of last month. This is because Novavax is likely to be used for additional vaccinations, so-called booster shots, in a situation where most people have been vaccinated with different
